| 1000-9 | DBG Ab from Blood product unit (qualitative) |
| 100002-5 | Specimen care is maintained (qualitative) |
| 100003-3 | Team communication is maintained throughout care (qualitative) |
| 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure (qualitative) |
| 100005-8 | Demonstrates knowledge of nutritional management related to the procedure (qualitative) |
| 100006-6 | Demonstrates knowledge of medication management (qualitative) |
| 100007-4 | Demonstrates knowledge of pain management (qualitative) |
| 100008-2 | Demonstrates knowledge of wound management (qualitative) |
| 100009-0 | Demonstrates knowledge of the procedure and expected results (qualitative) |
| 100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation (qualitative) |
| 100011-6 | No injury related to an electrical source (qualitative) |
| 100012-4 | Participates in decisions affecting the patient's plan of care (qualitative) |
| 100013-2 | Participates in the discharge process (qualitative) |
| 100014-0 | Psychosocial health is maintained at or improved from baseline (qualitative) |
| 100015-7 | No injury related to positioning due to care or procedure (qualitative) |
| 100016-5 | No injury related to a laser source (qualitative) |
| 100064-5 | Itch severity Reporting Period - Reported (qualitative) |
| 100065-2 | Satisfied with treatment (qualitative) |
| 100087-6 | Toxocara canis 24-35kD IgG Ab (qualitative, immunoblot) |
| 100089-2 | Taenia solium larva 6-8kD Ab (qualitative, immunoblot) |
| 100090-0 | Taenia solium larva 45kD Ab (qualitative, immunoblot) |
| 100093-4 | Trypanosoma cruzi 15-16kD IgG Ab (qualitative, immunoblot) |
| 100094-2 | Trypanosoma cruzi 21-22kD IgG Ab (qualitative, immunoblot) |
| 100095-9 | Trypanosoma cruzi 27-28kD IgG Ab (qualitative, immunoblot) |
| 100096-7 | Trypanosoma cruzi 42kD IgG Ab (qualitative, immunoblot) |
| 100097-5 | Trypanosoma cruzi 45-47kD IgG Ab (qualitative, immunoblot) |
| 100098-3 | Trypanosoma cruzi 120-200kD IgG Ab (qualitative, immunoblot) |
| 100099-1 | Trypanosoma cruzi 160kD IgG Ab (qualitative, immunoblot) |
| 1001-7 | DBG Ab from Donor (qualitative) |
| 100100-7 | Fasciola sp IgG Ab (qualitative, immunoassay) |
| 100101-5 | Fasciola sp 8-9kD IgG Ab (qualitative, immunoblot) |
| 100102-3 | Fasciola sp 27-28kD IgG Ab (qualitative, immunoblot) |
| 100103-1 | Fasciola sp 60kD IgG Ab (qualitative, immunoblot) |
| 100104-9 | Fasciola sp 42kD IgG Ab (qualitative, immunoblot) |
| 100106-4 | Filaria IgG Ab (qualitative, immunoassay) |
| 100107-2 | Leishmania sp IgG Ab (qualitative, immunoassay) |
| 100110-6 | Leishmania sp 14kD IgG Ab (qualitative, immunoblot) |
| 100111-4 | Leishmania sp 16kD IgG Ab (qualitative, immunoblot) |
| 100114-8 | Toxoplasma gondii 30kD Ab (qualitative, immunoblot) |
| 100115-5 | Toxoplasma gondii 31kD Ab (qualitative, immunoblot) |
| 100116-3 | Toxoplasma gondii 33kD Ab (qualitative, immunoblot) |
| 100117-1 | Toxoplasma gondii 40kD Ab (qualitative, immunoblot) |
| 100118-9 | Toxoplasma gondii 41kD Ab (qualitative, immunoblot) |
| 100119-7 | Toxoplasma gondii 45kD Ab (qualitative, immunoblot) |
| 100121-3 | Chlamydia trachomatis IgA Ab (qualitative, immunoassay) |
| 100123-9 | Chlamydophila pneumoniae IgA Ab (qualitative, immunoassay) |
| 100130-4 | Schistosoma mansoni Ab (qualitative, immunoblot) |
| 100131-2 | Schistosoma sp 8kD Ab (qualitative, immunoblot) |
| 100132-0 | Schistosoma sp 9kD Ab (qualitative, immunoblot) |
| 100133-8 | Schistosoma sp 10kD Ab (qualitative, immunoblot) |
| 100134-6 | Schistosoma sp 11kD Ab (qualitative, immunoblot) |
| 100135-3 | Schistosoma sp 12-13kD Ab (qualitative, immunoblot) |
| 100136-1 | Schistosoma sp 14-15kD Ab (qualitative, immunoblot) |
| 100137-9 | Schistosoma sp 15-16kD Ab (qualitative, immunoblot) |
| 100138-7 | Schistosoma sp 18-19kD Ab (qualitative, immunoblot) |
| 100139-5 | Schistosoma sp 22-24kD Ab (qualitative, immunoblot) |
| 100140-3 | Schistosoma sp 30-34kD Ab (qualitative, immunoblot) |
| 100141-1 | Schistosoma sp 65kD Ab (qualitative, immunoblot) |
| 100142-9 | Schistosoma sp 70kD Ab (qualitative, immunoblot) |
| 100143-7 | Schistosoma sp 80kD Ab (qualitative, immunoblot) |
| 100144-5 | Schistosoma sp 95kD Ab (qualitative, immunoblot) |
| 100145-2 | Schistosoma sp 110kD Ab (qualitative, immunoblot) |
| 100146-0 | Schistosoma sp 120kD Ab (qualitative, immunoblot) |
| 100160-1 | Knee replacement (qualitative) |
| 100161-9 | Charnley Functional Classification (qualitative) |
| 100162-7 | Knee alignment W standing X-ray measured (qualitative) |
| 100163-5 | Knee medial AndOr lateral instability W full extension (qualitative) |
| 100164-3 | Knee AP instability W 90 degree flexion (qualitative) |
| 100166-8 | Flexion contracture range of Knee (qualitative) |
| 100167-6 | Extensor lag range of Knee (qualitative) |
| 100168-4 | Knee pain severity with level walking (qualitative) |
| 100169-2 | Knee pain severity with stairs or inclines (qualitative) |
| 100170-0 | Knee feels normal (qualitative) |
| 100171-8 | Satisfaction with level of knee pain while sitting (qualitative) |
| 100172-6 | Satisfaction with level of knee pain while lying in bed (qualitative) |
| 100173-4 | Satisfaction with knee function while getting out of bed (qualitative) |
| 100174-2 | Satisfaction with knee function while performing light household duties (qualitative) |
| 100175-9 | Satisfaction with knee function while performing recreational activities (qualitative) |
| 100176-7 | Expect surgery to relieve pain (qualitative) |
| 100177-5 | Expect surgery will improve ability to perform activities of daily living (qualitative) |
| 100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities (qualitative) |
| 100179-1 | Walk without assistive mobility devices (qualitative) |
| 100181-7 | Assistive mobility devices used due to health condition (qualitative) |
| 100182-5 | Duration of standing before sitting due to knee discomfort (qualitative) |
| 100183-3 | Duration of walking before stopping due to knee discomfort (qualitative) |
| 100184-1 | How bothersome is knee when walking on an uneven surface (qualitative) |
| 100185-8 | How bothersome is knee when turning or pivoting leg (qualitative) |
| 100186-6 | How bothersome is knee when climbing up or down a flight of stairs (qualitative) |
| 100187-4 | How bothersome is knee when getting up from a low seat without armrests (qualitative) |
| 100188-2 | How bothersome is knee when getting into or out of a car (qualitative) |
| 100189-0 | How bothersome is knee when moving laterally (qualitative) |
| 100190-8 | How bothersome is knee when climbing a ladder or step stool (qualitative) |
| 100191-6 | How bothersome is knee when carrying a bag for one block (qualitative) |
| 100192-4 | How bothersome is knee when squatting (qualitative) |
| 100193-2 | How bothersome is knee when kneeling (qualitative) |
| 100194-0 | How bothersome is knee when running (qualitative) |
| 100195-7 | Pain severity--during activity (qualitative) |
| 1002-5 | DBG Ab (qualitative) |
| 100204-7 | Accuracy of pre-surgery expectations of pain relief (qualitative) |
| 100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living (qualitative) |